Trastuzumab deruxtecan
Trastuzumab deruxtecan
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-0905 | 1mg | 880.00 | + Add to cart |
|
| R-R-0905 | 5mg | 2150.00 | + Add to cart |
|
|
|
||||
Product description
Trastuzumab deruxtecan (DS-8201a)/CAS No.1826843-81-5 is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Purity | >90% |
| CAS | 1826843-81-5 |
| Synonyms | DS-8201; DS-8201a |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Trastuzumab deruxtecan
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


